Torrey Pines Investment
Venture capitalSan Diego · Seed–Series A · 7 people tracked
Find your way into Torrey Pines Investment
Investment thesis
Torrey Pines Investment focuses on the life-sciences sector, backing biopharma and diagnostics accelerators and investing in early development-stage assets from pharma and biotech partners across CNS, oncology, and virology areas. The firm aims to advance these assets toward success through pharma partnering and M&A. It supports portfolio companies with both product and corporate development, drawing on expertise in drug discovery — including non-clinical and clinical studies, manufacturing and quality, and regulatory affairs — to help them achieve growth, build value, and realize wealth.
Source: firm website, verified Aug 3, 2026.
Team · 7 people
from the firm's website & public directories
What they invest in
from 10 of 13 portfolio companiesBiotech ×8Healthtech ×7Medical Devices ×3AI & Machine Learning ×2Deep Tech ×2Digital Health ×2Marketing Tech ×1SaaS ×1
HQs:United States×4Finland×1
Investments · 13 tracked
founders shown can be your intro pathBy year:2024 · 12021 · 12 dated
Context Therapeutics develops clinical-stage T cell engaging bispecific antibody therapies for the treatment of solid tumors.
BiotechHealthtechPhiladelphia, US
Martin Lehr(Founder)inJennifer Minai-Azary(Executive Officer)inAlex Levit(Executive Officer)Linda Beth West(Director)Richard Jay Berman(Director)Philip Kantoff(Director)in
Co-investorsNextech Invest
Brenig Therapeutics is a biotechnology company developing small-molecule therapies for Parkinson's disease and other neurodegenerative disorders, using AI-driven drug discovery.
AI & Machine LearningBiotechHealthtech
Megan McGill(Chief Executive Officer)inIain Dukes(Chief Business Officer / Chairman of the Board)inNikolay Savchuk(Chief Operating Officer)Tien Dam(Chief Medical Officer)in
Co-investorsNew Enterprise Associates (NEA)OrbiMedBGV
i2020 Accelerator (T123 LLC) is a drug discovery accelerator that de-risks early-stage science and advances drug discovery platforms toward lead and clinical candidate stage within roughly two years, working across therapeutic areas such as oncology, immunology, and infectious diseases.
BiotechDeep TechHealthtechSan Diego, US
Co-investorsBioGeneration VenturesOrbiMedBGV
19Labs builds GALE, a smart point-of-care platform that brings a full clinic experience to schools, rural communities, and pharmacies.
Digital HealthHealthtechMedical Devices
Ram Fish(Founder & CEO)inGerald Horel(Founder)in
Co-investorsTransPacific Venture Partners
Contract research organization specializing in CNS preclinical efficacy and neurotoxicity evaluations using its patented Enhanced Spine Profiling (ESP) technology.
Clinical-stage drug-device company developing pegloprastide (AVB-620) for real-time surgical margin detection in cancer surgery.
Co-investorsAlexandria
Chromis Therapeutics is a biotech company with board members experienced in pharmaceutical development, corporate development, and healthcare investments.
BiotechHealthtechMedical DevicesSan Diego, US
BoardNikolay Savchuk(Chairman of the Board)Ronald Demuth(Director of the Board)Jennifer Giottonini Cayer(Director of the Board)
Elpida provides automated regulatory compliance monitoring for healthcare brands' digital communications.
AI & Machine LearningHealthtechMarketing TechSaaS
Co-investorsfresh.fundSkolkovo Foundation
Polku Therapeutics is a preclinical CNS drug discovery company developing small-molecule therapies that modulate the PREP–PP2A axis to target tau aggregation and neuroinflammation in neurodegenerative diseases.
BiotechDeep Tech
Timo(Scientific Co-founder)inErik(Scientific Co-founder)inSimon(Chief Executive Officer)inSebastian(Chief Operating Officer)in
Co-investorsInnovestor
Biotechnology company enhancing vaccine performance with its HD-MAP high-density microarray skin-delivery platform, targeting infectious disease and oncology.
Co-investorsR&D Tax IncentiveOneVentures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Exits · 1
1 IPOsContext TherapeuticsNASDAQ: CNTX
Portfolio news
latest coverage across their companiesLeap Therapeutics · ad-hoc-news.de · May 19, 2026
Vaxxas · amtil.com.au · Sep 1, 2025
Frequently asked questions
- How many investments has Torrey Pines Investment made?
- Torrey Pines Investment has 13 tracked investments, 1 of which have exited.
- What stage does Torrey Pines Investment invest at?
- Torrey Pines Investment invests at the Seed, Series A stages.
- What sectors does Torrey Pines Investment focus on?
- Torrey Pines Investment focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Torrey Pines Investment located?
- Torrey Pines Investment is headquartered in San Diego, US.
- Does Torrey Pines Investment lead rounds?
- Yes, Torrey Pines Investment leads investment rounds.
- Who does Torrey Pines Investment co-invest with?
- Torrey Pines Investment most often shares deals with Nextech Invest, OneVentures, R&D Tax Incentive, among 3 tracked co-investors.
Images
Similar investors
US Venture Partners (USVP) is an early-stage venture capital firm investing in information technology and healthcare companies, with four decades of investing experience.
Wavemaker 360 is a healthcare-focused venture capital firm that backs entrepreneurs building disruptive companies transforming the healthcare industry. Its limited partners are largely individuals with significant healthcare industry experience.
HealthQuad is a healthcare-focused investment firm that partners with entrepreneurs building category-defining healthcare businesses, leveraging its healthcare network and clinical/operating expertise.
Next Ventures is an investment firm that backs founders building solutions to improve health care access and enhance human capability.
CABHI (Centre for Aging + Brain Health Innovation) is a pan-Canadian organization that funds and supports researchers, innovators, and startups working on brain health and aging solutions, and helps healthcare and community organizations adopt them.